MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer

Although combination chemotherapy is widely used for bladder cancer (BC) treatment, the recurrence and progression rates remain high. Therefore, novel therapeutic targets are required. Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) contributes to tumourigenesis and immune evasion in several canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linzhi, Zhang, Yunlong, Hu, Weimin, Zou, Fan, Ning, Jinzhuo, Rao, Ting, Ruan, Yuan, Yu, Weimin, Cheng, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538262/
https://www.ncbi.nlm.nih.gov/pubmed/37480214
http://dx.doi.org/10.1111/jcmm.17863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538262/
https://www.ncbi.nlm.nih.gov/pubmed/37480214
http://dx.doi.org/10.1111/jcmm.17863

Ejemplares similares